Abstract:Doxorubicin (DOX) is one of the most commonly used anticancer drugs; however, its clinical application is greatly limited due to its toxicity and chemotherapy resistance. The delivery of DOX by liposomes (Lipos) can improve the blood circulation time in vivo and reduce toxic side effects, but the drug's accumulation in the tumor is often insufficient for effective treatment. In this study, we present a calcium cross-linked liposome gel for the encapsulation of DOX, demonstrating its superior long-term release capabilities compared to conventional Lipos. By leveraging this enhanced long-term release, we can enhance drug accumulation within tumors, ultimately leading to improved antitumor efficacy. Lipos were prepared using the thin-film dispersion method in this study. We utilized the ion-responsiveness of glutathione-gelatin (GSH-GG) to form the gel outside the Lipos and named the nanoparticles coated with GSH-GG on the outside of Lipos as Lipos@GSH-GG. The average size of Lipos@GSH-GG was around 342.9 nm, with a negative charge of -25.6 mV. The in vitro experiments revealed that Lipos@GSH-GG exhibited excellent biocompatibility and slower drug release compared to conventional Lipos. Further analysis of cellular uptake and cytotoxicity demonstrated that Lipos@GSH-GG loading DOX (DOX&Lipos@GSH-GG) exhibited superior long-term release effects and lower toxic side effects compared to Lipos loading DOX (DOX&Lipos). Additionally, the findings regarding the long-term release effect in vivo and the tumor accumulation within tumor-bearing mice of Lipos@GSH-GG suggested that, compared to Lipos, it demonstrated superior long-term release capabilities and achieved greater drug accumulation within tumors. In vivo antitumor efficacy experiments showed that DOX&Lipos@GSH-GG demonstrated superior antitumor efficacy to DOX&Lipos. Our study highlights Lipos@GSH-GG as a promising nanocarrier with the potential to enhance efficacy and safety by means of long-term release effects and may offer an alternative approach for effective antitumor therapy in the future.

Study of the preparation technology of Doxorubicin nanoliposomes

Preparation and Characterization of Modified Lipid Nanoparticles for Doxorubicin Controlled Release.

Green Preparation Process, Characterization and Antitumor Effects of Doxorubicin-Bsa-dextran Nanoparticles.

Preparation of Doxorubicin Liposomes by Remote Loading Method.

Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin

Preparation and Characterization of TPGS-Modified Doxorubicin Liposomes

Lipid Nanoemulsions Loaded with Doxorubicin-Oleic Acid Ionic Complex: Characterization, in Vitro and in Vivo Studies.

Preparation of Doxorubicin Loaded Self-Aggregated Nanoparticles Based on Cholesterol-Modified Glycol Chitosan Conjugate and Its Pharmacokinetics in Rats

Preparation of small particle size of doxorubicin hydrochloride albumin microspheres and determination of doxorubicin content by HPLC

Preparation and characterization of β-casein stabilized lipopeptide lyotropic liquid crystal nanoparticles for delivery of doxorubicin

Preparation and Characteristics of Doxorubicin Alginate Microspheres

Doxorubicin hydrochloride-oleic acid conjugate loaded nanostructured lipid carriers for tumor specific drug release.

Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy

Preparation of Liposome Gel by Calcium Cross-Linking Induces the Long-Term Release of DOX to Improve the Antitumor Effect

Preparation, Drug Release and Cellular Uptake of Doxorubicin-Loaded Dextran-B-poly(ɛ-caprolactone) Nanoparticles

Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery

Preparation of Ph-Sensitive Doxorubicin Liposomes Modified with Carboxymethyl Chitosan and in Vitro Cell Research

Nanometer particle loaded with doxorubicin hydrochloride as well as preparation method and purpose thereof

Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface.

Study on preparation and characterization of poly(β-malic-acid)-doxorubicin/do-cetaxel nanoconjugate

Preparation of Epidermal Growth Factor-Modified Targeted Doxorubicin Nanoliposomes and Therapy of Liver Cancer